Clinical Trials Browser

Recruiting × Solid Tumor × atezolizumab × Clear all

NCT05907980 2025-03-06

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor